CIBC World Market’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-2,198
Closed -$223K 821
2017
Q2
$223K Buy
+2,198
New +$237K ﹤0.01% 1046
2017
Q1
Sell
-1,952
Closed -$234K 1012
2016
Q4
$234K Buy
+1,952
New +$216K ﹤0.01% 958
2016
Q3
Sell
-1,652
Closed -$205K 1010
2016
Q2
$205K Buy
+1,652
New +$199K ﹤0.01% 856

Other funds holding CLB

CIBC World Market's CLB Position: Q3 2017 in Review

CIBC World Market sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 2,198 shares — an estimated $223K sold.

CIBC World Market first reported a position in CLB in Q2 2016 and held it in 3 quarters. The position peaked at $234K in Q4 2016. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • CIBC World Market reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • CIBC World Market sold 2,198 Core Laboratories shares in Q3 2017, an estimated $223K.
  • CIBC World Market first reported a position in Core Laboratories in Q2 2016 and held it in 3 quarters.
  • CIBC World Market's Core Laboratories position peaked at $234K in Q4 2016.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on CIBC World Market's 13F filing for Q3 2017, filed 13 Nov 2017.